fda warning letters glp-1 compounders september 2025 Drug Recalls and Warnings: Recalls for Compounded Semaglutide and Tirzepatide, Wegovy; Facility Congress Introduces SAFE Drugs Act

Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension

Its also possible that many of your clients could already take these medications

academic.oup.com/jes/article/9/ GLP-1 in addiction medicine: GLP-1 acts on pancreas, gut, kidney, heart and thyroid receptors to activate reward/stress hubs (VTA, NAc, ARC, PFC, hypothalamus)

These medications are powerful tools, but they work best as part of a comprehensive approach to health that includes diet, exercise, and lifestyle changes

Recent developments in therapeutic peptides for the glucagon-like peptide 1 and 2 receptors

Severe sepsis and cardiac arrhythmias